Project Grant R01NS136739

Award Date 6/15/24
Completion Date 5/31/29
Dollars Obligated $1.5M
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94115, USA
Similar Awards
This $2,068,842 federal Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to dissect the role of prefrontal cortex dynorphin circuits in modulating different pain states. The research aims to identify pain-induced adaptations in the prefrontal cortical dynorphin/kappa-opioid receptor system and its influence on pain-induced maladaptive behavior and nociception. Through...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $456,840.00 to The Leland Stanford Junior University to conduct research on the role of pain-facilitating circuits in chronic pain after traumatic brain injury (TBI). The key objective is to characterize the functional and electrophysiological changes in descending...
The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an $11.2 million project grant to the University of Pittsburgh to define the mechanisms of pain relief associated with dorsal root ganglion and spinal cord stimulation. This three-year grant will support research under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to advance understanding of neuromodulatory devices for chronic pain treatment. The University will conduct preclinical...
This $14.2 million project grant from the National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services, will fund research from September 2022 to August 2025 under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The Massachusetts General Hospital will investigate the mechanisms by which spinal cord stimulation reduces pain, with the goal of improving device design and patient selection. Researchers will apply specialized nerve...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $246,750 to support research on the role of the mesocortical glutamatergic pathway in the development and treatment of chronic neuropathic pain. The research, led by The Trustees of Columbia University in the City of New York, will examine how changes in glutamatergic...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a 5-year, $453,104 Project Grant (CFDA 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders) to The University of Texas Southwestern Medical Center. The grant will fund research to explore the role of two key subtypes of spinal projection neurons, TACR1-expressing and GPR83-expressing neurons, in transmitting pain signals to the brain and their potential as therapeutic targets for...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,314,276.00 in funding to Emory University to develop novel methods for selectively stimulating nociceptors and measuring nociceptive-specific brain activations. The project aims to overcome limitations in current experimental pain testing by identifying skin regions devoid of innocuous warm fibers, allowing for unbiased...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $6,522,833 Project Grant to The Leland Stanford Junior University to conduct a mechanistic randomized clinical trial investigating the central and peripheral nervous system mechanisms of pain relief induced by peripheral nerve stimulation (PNS) for the treatment of refractory chronic neuropathic pain. The 3-year study, funded under the NIH HEAL Initiative's CFDA 93.279 Drug Abuse and Addiction Research Programs, aims...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is funding research to dissociate sensory and integrative pain processes in the human insula. The $231,000 award to The Leland Stanford Junior University aims to determine whether electrical stimulation of distinct insula subregions can differentially modulate sensory pain and higher-order,...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, supports research to understand how the dorsal column nuclei (DCN) in the brainstem process and transmit tactile information, and how disruption of this circuit contributes to persistent, touch-evoked pain. The $391,830 award, spanning Jul 2024 to Jun 2026, will enable the...

CORTICOTHALAMIC NETWORK FUNCTION IN CHRONIC PAIN - PROJECT SUMMARY THIS STUDY FOCUSES ON UNDERSTANDING THE COMPLEX NATURE OF CHRONIC PAIN BY INVESTIGATING THE COMMUNICATION BETWEEN DISTINCT BRAIN CIRCUITS. WE AIM TO UNRAVEL THE MECHANISMS BY WHICH SOMATOSENSORY, COGNITIVE, AND AFFECTIVE INFORMATION IS INTEGRATED TO PRODUCE THE PERCEPT OF PAIN. BY STUDYING NETWORK DYNAMICS ACROSS KEY BRAIN REGIONS USING DIRECT INTRACRANIAL RECORDINGS AND GRAPH THEORY APPROACHES, WE WILL ELUCIDATE SPATIOTEMPORAL ACTIVITY PATTERNS THAT UNDERLIE THE AFFECTIVE AND COGNITIVE DIMENSIONS OF PAIN. PREVIOUS STUDIES HAVE IDENTIFIED SPECIFIC BRAIN REGIONS, SUCH AS THE ANTERIOR CINGULATE CORTEX (ACC), MEDIAL PREFRONTAL CORTEX (MPFC), INSULA, SENSORY AND MEDIAL THALAMUS, PERIVENTRICULAR GREY MATTER, AND PRIMARY SENSORIMOTOR CORTICES, AS CRUCIAL HUBS INVOLVED IN REGULATING CHRONIC PAIN TRAITS. HOWEVER, THE DYNAMIC FUNCTIONING OF THESE NETWORKS IN INFLUENCING THE FLUCTUATING NATURE OF CHRONIC PAIN, WHICH CAN VARY OVER MINUTES TO DAYS, REMAINS LESS UNDERSTOOD. TO BRIDGE THIS KNOWLEDGE GAP, THE STUDY PROPOSES THE USE OF DIRECT INTRACRANIAL RECORDINGS FROM PATIENTS WITH CHRONIC PAIN AND COMBINES THEM WITH GRAPH THEORY APPROACHES TO ANALYZE NETWORK DYNAMICS. WE AIM TO STUDY PAIN CIRCUITS IN THE LABORATORY AND NATURALISTIC ENVIRONMENTS BY INVESTIGATING THE IMPACT OF EXPECTATION AND MOOD ON DESCENDING CIRCUITS AND DETERMINING IF THEY INFLUENCE PAIN THROUGH SIMILAR MECHANISMS. THE HYPOTHESIS IS THAT BRAIN STIMULATION RELIEVING PAIN ENGAGES DESCENDING CONTROL MECHANISMS SIMILAR TO POSITIVE MOOD OR EXPECTATION, WHILE A BREAKDOWN IN CORTICOTHALAMIC FUNCTIONAL CONNECTIVITY IS ASSOCIATED WITH EPISODES OF ELEVATED PAIN. THE STUDY PROPOSES THREE SPECIFIC AIMS. AIM 1 INVOLVES ANALYZING INTRACRANIAL RECORDINGS FROM CHRONIC PAIN PATIENTS TO TRACK CHANGES IN FUNCTIONAL CONNECTIVITY WITHIN CORTICOTHALAMIC NETWORKS DURING SPONTANEOUS PAIN AND PAIN-RELIEVING BRAIN STIMULATION. AIM 2 FOCUSES ON EXAMINING THE INTERACTION BETWEEN ASCENDING AND DESCENDING CIRCUITS DURING A COGNITIVE PAIN-EXPECTATION TASK USING RECORDINGS FROM PATIENTS WITH DBS ELECTRODES. AIM 3 INVESTIGATES THE ROLE OF AFFECTIVE STATE ON PAIN PERCEPTION AND DESCENDING PAIN CIRCUITS DURING A MOOD MODULATING TASK. OUR GROUP AIMS TO IDENTIFY PATTERNS OF FUNCTIONAL CONNECTIVITY AND COHERENCE BETWEEN KEY BRAIN HUBS, SUCH AS THE ACC, MEDIAL PREFRONTAL CORTEX, INSULA, AND THALAMUS, AND UNDERSTAND THEIR RELATIONSHIP WITH PAIN PERCEPTION. BY CLARIFYING THE UNDERLYING MECHANISMS OF CHRONIC PAIN AND THE EFFECTS OF BRAIN STIMULATION, MOOD, AND EXPECTATION, THIS STUDY HAS THE POTENTIAL TO CONTRIBUTE TO THE DEVELOPMENT OF NOVEL DIAGNOSTIC TOOLS AND MORE EFFECTIVE TREATMENTS FOR CHRONIC PAIN DISORDERS.

Posted 6/12/24, 12:00 AM